PDS Biotechnology Corporation
USD0.76
+0.04 (+6.27%)
CEO
Frank K. Bedu-Addo
IPO Date
2015-09-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.73
Prev. Close
$0.72
Day Low
$0.72
Day High
$0.77
52W Low
$0.51
52W High
$1.55
Market Cap
$0.04B
Volume
0.21M
| 150,000 |
| $0.98 |
| 3 Mar 2026 | Shepard Kirk V. | Chief Medical Officer | A-Award | Acquired | 300,000 | $0.98 |
| 3 Mar 2026 | Boesgaard Lars | Chief Financial Officer | A-Award | Acquired | 300,000 | $0.98 |
| 3 Mar 2026 | Brown Spencer D. | Senior VP, General Counsel | A-Award | Acquired | 300,000 | $0.98 |
| 3 Mar 2026 | Toutain Stephan | Chief Operating Officer | A-Award | Acquired | 300,000 | $0.98 |
| 3 Mar 2026 | Freitag Gregory Gene | director | A-Award | Acquired | 54,876 | $0.98 |
| 3 Mar 2026 | Iliev Ilian | director | A-Award | Acquired | 54,876 | $0.98 |
| 3 Mar 2026 | Ali-Jackson Kamil | director | A-Award | Acquired | 54,876 | $0.98 |
| 3 Mar 2026 | BRAWLEY OTIS W | director | A-Award | Acquired | 54,876 | $0.98 |